Trials / Completed
CompletedNCT00355589
Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension
A Randomized, Double-Blind, Multicenter, Parallel Study Evaluating the Efficacy and Safety of a Combination of Ramipril Plus Hydrochlorothiazide Versus the Component Monotherapies in Subjects With Essential Hypertension
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if there is greater blood pressure reduction using ramipril or hydrochlorothiazide alone or ramipril and hydrochlorothiazide together.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ramipril and hydrochlorothiazide |
Timeline
- Start date
- 2006-07-01
- Primary completion
- 2007-03-01
- Completion
- 2007-03-01
- First posted
- 2006-07-24
- Last updated
- 2012-10-10
Locations
60 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00355589. Inclusion in this directory is not an endorsement.